A Phase 1, Open Label, Randomized, Crossover, Drug Interaction Study of the Pharmacokinetics of ASP1941 and Sitagliptin After Separate and Concomitant Administration to Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 01 Oct 2012
At a glance
- Drugs Ipragliflozin (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 01 Oct 2012 Results published in the Diabetes, Obesity and Metabolism.
- 19 Apr 2010 New trial record